Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 72

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 1
Chunk 72
---
 liabilities$1,265 $— $1,265 $— Other long-term liabilities23 — 23 — Interest rate contracts:Other long-term liabilities2,384 — 2,384 — Total Liabilities$3,672 $— $3,672 $—  Fair value measurements as of December 31, 2024 Total carryingvalueQuoted pricesin activemarkets foridenticalassets (level 1)Significantotherobservableinputs (level 2)Significantunobservableinputs (level 3)Assets:Foreign exchange contracts:Prepaid expenses and other current assets$6,716 $— $6,716 $— Interest rate contracts:Prepaid expenses and other current assets11,038 — 11,038 — Other assets5,724 — 5,724 — Total Assets$23,478 $— $23,478 $— Liabilities:Foreign exchange contracts:Accrued liabilities$7,391 $— $7,391 $— Total Liabilities$7,391 $— $7,391 $— Nonrecurring Fair Value MeasurementsWe measure certain items on a nonrecurring basis due to particular circumstances or when specific transactions occur such as a retained investment resulting from a partial sale. On May 1, 2025, we measured our retained equity method investment in Otsuka ICU Medical LLC (see Note 11: Investment Securities) at fair value in connection to the sale of a 60% 

25

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

interest of our IV Solutions business (see Note 4: Assets Held for Sale and Disposal of Business). The fair value was estimated using a market-based approach and is classified as a Level 3 fair value measurement. 

Note 11:  Investment Securities

Investments in Non-Marketable Equity SecuritiesInvestments in Unconsolidated AffiliatesWe hold equity method investments in certain entities. We apply the equity method of accounting for investments in unconsolidated affiliates when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of